News Headline Summary

Sarepta's (SRPT) experimental drug shows promise for local boy with muscular dystrophy according to WPXI

Full article:

Reaction details (17:14)

Shares jumped 1.21% in immediate reaction to the news, from USD 24.68 to USD 24.95.

06 Nov 2012 - 17:11 - Equities - Source: WPXI

Subscribe Now to RANsquawk

Click here for a 1 week free trial

RANsquawk provides audio news and commentary for over 15,000 professional traders and brokers worldwide. Services include: